{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:48:29Z","timestamp":1792673309074,"version":"4.5.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Maternal Health Innovation Project"},{"DOI":"10.13039\/100018450","name":"Wisconsin Department of Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018450","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jalm\/jfag154","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:31:08Z","timestamp":1792672268000},"source":"Crossref","is-referenced-by-count":0,"title":["Lingering Norfentanyl: Considerations for Prolonged Clearance in Pregnancy Given Potential Clinical and Legal Implications"],"prefix":"10.1093","author":[{"given":"Laura","family":"Smy","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical College of Wisconsin , Milwaukee, WI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Boden","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Froedtert Hospital , West Bend, WI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Cabacungan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin , Milwaukee, WI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin , Milwaukee, WI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hovis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical College of Wisconsin , Milwaukee, WI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102208310058100_jfag154-B1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jat\/28.6.422","article-title":"Urine concentrations of fentanyl and norfentanyl during application of Duragesic transdermal patches","volume":"28","author":"Poklis","year":"2004","journal-title":"J Anal Toxicol"},{"key":"2026102208310058100_jfag154-B2","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy","volume":"130","author":"American College of Obstetricians and Gynecologists","year":"2017","journal-title":"Obstet Gynecol"},{"key":"2026102208310058100_jfag154-B3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.whi.2016.12.008","article-title":"Characterization of U.S. state laws requiring health care provider reporting of perinatal substance use","volume":"27","author":"Jarlenski","year":"2017","journal-title":"Womens Health Issues"},{"key":"2026102208310058100_jfag154-B4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive summary: American Association for Clinical Chemistry Laboratory Medicine practice guideline\u2014using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J Appl Lab Med"},{"key":"2026102208310058100_jfag154-B5","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"key":"2026102208310058100_jfag154-B6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/AOG.0000000000004106","article-title":"Delayed norfentanyl clearance during pregnancy","volume":"136","author":"Wanar","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2026102208310058100_jfag154-B7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl","volume":"17","author":"Bird","year":"2023","journal-title":"J Addict Med"},{"key":"2026102208310058100_jfag154-B8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/14622416.2025.2562796","article-title":"Scoping review of associations between cytochrome P450 3A4\/5 single nucleotide polymorphisms and risk factors for fentanyl overdose","volume":"26","author":"Petrovitch","year":"2025","journal-title":"Pharmacogenomics"},{"key":"2026102208310058100_jfag154-B9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40262-015-0267-1","article-title":"Impact of genetic polymorphisms of ABCB1 (MDR1, P-glycoprotein) on drug disposition and potential clinical implications: update of the literature","volume":"54","author":"Wolking","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"2026102208310058100_jfag154-B10","volume-title":"Applied biopharmaceutics and pharmacokinetics","author":"Shargel","year":"2022","edition":"8th Ed"},{"key":"2026102208310058100_jfag154-B11","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1111\/bcp.14735","article-title":"Effect of lipophilicity on drug distribution and elimination: influence of obesity","volume":"87","author":"Bruno","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2026102208310058100_jfag154-B12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","article-title":"Extended urinary \u03949-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure","volume":"105","author":"Lowe","year":"2009","journal-title":"Drug Alcohol Depend"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/advance-article-pdf\/doi\/10.1093\/jalm\/jfag154\/72348382\/jfag154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/advance-article-pdf\/doi\/10.1093\/jalm\/jfag154\/72348382\/jfag154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:31:11Z","timestamp":1792672271000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/advance-article\/doi\/10.1093\/jalm\/jfag154\/8978621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfag154","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"article-number":"jfag154"}}